| Descriptor English: | Anti-Arrhythmia Agents | ||||||
| Descriptor Spanish: |
Antiarrítmicos
| ||||||
| Descriptor Portuguese: | Antiarrítmicos | ||||||
| Descriptor French: | Antiarythmiques | ||||||
| Entry term(s): |
Agent, Anti-Arrhythmia Agent, Antiarrhythmia Agent, Antifibrillatory Agents, Anti-Arrhythmia Agents, Antiarrhythmia Agents, Antifibrillatory Anti Arrhythmia Agent Anti Arrhythmia Agents Anti Arrhythmia Drug Anti Arrhythmia Drugs Anti Arrhythmic Anti Arrhythmics Anti-Arrhythmia Agent Anti-Arrhythmia Drug Anti-Arrhythmia Drugs Anti-Arrhythmic Anti-Arrhythmics Antiarrhythmia Agent Antiarrhythmia Agents Antiarrhythmia Drug Antiarrhythmia Drugs Antiarrhythmic Drug Antiarrhythmic Drugs Antifibrillatory Agent Antifibrillatory Agents Cardiac Depressant Cardiac Depressants Depressant, Cardiac Depressant, Myocardial Depressants, Cardiac Depressants, Myocardial Drug, Anti-Arrhythmia Drug, Antiarrhythmia Drug, Antiarrhythmic Drugs, Anti-Arrhythmia Drugs, Antiarrhythmia Drugs, Antiarrhythmic Myocardial Depressant Myocardial Depressants |
||||||
| Tree number(s): |
D27.505.954.411.097 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000889 | ||||||
| Scope note: | Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. |
||||||
| Annotation: | consider also ARRHYTHMIAS, CARDIAC /drug ther |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Public MeSH Note: | 76; was MYOCARDIAL DEPRESSANTS 1963-75 |
||||||
| Online Note: | use ANTI-ARRHYTHMIA AGENTS to search MYOCARDIAL DEPRESSANTS 1966-75 |
||||||
| History Note: | 76; was NON MESH before 1976; MYOCARDIAL DEPRESSANTS was heading 1963-75 |
||||||
| Related: |
Adrenergic beta-Antagonists
MeSH Calcium Channel Blockers MeSH | ||||||
| DeCS ID: | 902 | ||||||
| Unique ID: | D000889 | ||||||
| NLM Classification: | QV 152 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1976/01/01 | ||||||
| Date of Entry: | 1975/07/25 | ||||||
| Revision Date: | 2020/05/27 |
-
-
CHEMICALS AND DRUGS
Chemical Actions and Uses [D27]Chemical Actions and Uses
|
|
Anti-Arrhythmia Agents
- Preferred
Cardiac Depressants
- Related but not broader or narrower
Antifibrillatory Agents
- Narrower
| Concept UI |
M0001326 |
| Scope note | Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. |
| Preferred term | Anti-Arrhythmia Agents |
| Entry term(s) |
Agent, Anti-Arrhythmia Agent, Antiarrhythmia Agents, Anti-Arrhythmia Agents, Antiarrhythmia Anti Arrhythmia Agent Anti Arrhythmia Agents Anti Arrhythmia Drug Anti Arrhythmia Drugs Anti Arrhythmic Anti Arrhythmics Anti-Arrhythmia Agent Anti-Arrhythmia Drug Anti-Arrhythmia Drugs Anti-Arrhythmic Anti-Arrhythmics Antiarrhythmia Agent Antiarrhythmia Agents Antiarrhythmia Drug Antiarrhythmia Drugs Antiarrhythmic Drug Antiarrhythmic Drugs Drug, Anti-Arrhythmia Drug, Antiarrhythmia Drug, Antiarrhythmic Drugs, Anti-Arrhythmia Drugs, Antiarrhythmia Drugs, Antiarrhythmic |
| Concept UI |
M0001328 |
| Preferred term | Cardiac Depressants |
| Entry term(s) |
Cardiac Depressant Depressant, Cardiac Depressant, Myocardial Depressants, Cardiac Depressants, Myocardial Myocardial Depressant Myocardial Depressants |
| Concept UI |
M0001327 |
| Preferred term | Antifibrillatory Agents |
| Entry term(s) |
Agent, Antifibrillatory Agents, Antifibrillatory Antifibrillatory Agent |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
